Limitations of Raised Thyroglobulin: Two Cases of Benign Lymphadenopathy Mimicking Thyroid Carcinoma.

LaryngoscopeApr 6, 2026 (epub)
Case ReportEndocrinologyOncology (Medical)Open access

Shireen S Gohari, Isaac Wasserman, Justine Philteos et al.

✦ AI-curated · Sources linked

Case in brief

The report describes two patients with cervical lymphadenopathy whose lymph-node washout samples showed markedly elevated thyroglobulin, a finding often considered suggestive of metastatic differentiated thyroid cancer. However, pathology showed benign lymph nodes. Both patients were carriers of iron-handling disorders. The cases demonstrate that elevated washout thyroglobulin did not correspond to malignancy in these patients; the abstract does not provide further clinical details or describe subsequent management.

What made this case unusual

Markedly elevated thyroglobulin washout occurred in benign cervical lymph nodes in patients who carried iron-handling disorders, creating a potential diagnostic mimic of thyroid cancer metastasis.

Diagnostic / clinical pearl

Interpret lymph-node thyroglobulin washout alongside pathology and other clinical findings; it should not be used as a standalone marker of metastatic differentiated thyroid cancer.

Source

Published in Laryngoscope. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Endocrinology

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.